190 related articles for article (PubMed ID: 32804243)
1. PDCD4 limits prooncogenic neuregulin-ErbB signaling.
Montero JC; Pandiella A
Cell Mol Life Sci; 2021 Feb; 78(4):1799-1815. PubMed ID: 32804243
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.
González-Villasana V; Nieves-Alicea R; McMurtry V; Gutiérrez-Puente Y; Tari AM
Oncol Rep; 2012 Mar; 27(3):861-6. PubMed ID: 22200873
[TBL] [Abstract][Full Text] [Related]
3. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
5. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation.
Schmid T; Bajer MM; Blees JS; Eifler LK; Milke L; Rübsamen D; Schulz K; Weigert A; Baker AR; Colburn NH; Brüne B
Carcinogenesis; 2011 Oct; 32(10):1427-33. PubMed ID: 21771721
[TBL] [Abstract][Full Text] [Related]
7. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
[TBL] [Abstract][Full Text] [Related]
8. P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.
Montero JC; Seoane S; Ocaña A; Pandiella A
Oncogene; 2011 Mar; 30(9):1059-71. PubMed ID: 21042280
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.
Nieves-Alicea R; Colburn NH; Simeone AM; Tari AM
Breast Cancer Res Treat; 2009 Mar; 114(2):203-9. PubMed ID: 18386173
[TBL] [Abstract][Full Text] [Related]
10. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
Wen YH; Shi X; Chiriboga L; Matsahashi S; Yee H; Afonja O
Oncol Rep; 2007 Dec; 18(6):1387-93. PubMed ID: 17982621
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.
Frankel LB; Christoffersen NR; Jacobsen A; Lindow M; Krogh A; Lund AH
J Biol Chem; 2008 Jan; 283(2):1026-33. PubMed ID: 17991735
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.
Kroczynska B; Sharma B; Eklund EA; Fish EN; Platanias LC
Mol Cell Biol; 2012 Jul; 32(14):2809-22. PubMed ID: 22586265
[TBL] [Abstract][Full Text] [Related]
14. Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
Venturutti L; Romero LV; Urtreger AJ; Chervo MF; Cordo Russo RI; Mercogliano MF; Inurrigarro G; Pereyra MG; Proietti CJ; Izzo F; Díaz Flaqué MC; Sundblad V; Roa JC; Guzmán P; Bal de Kier Joffé ED; Charreau EH; Schillaci R; Elizalde PV
Oncogene; 2016 Apr; 35(17):2208-22. PubMed ID: 26212010
[TBL] [Abstract][Full Text] [Related]
15. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
16. miR-155 is high-expressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells.
Xia H; Zhao Y
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):197-205. PubMed ID: 31851829
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
18. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.
Esparís-Ogando A; Díaz-Rodríguez E; Montero JC; Yuste L; Crespo P; Pandiella A
Mol Cell Biol; 2002 Jan; 22(1):270-85. PubMed ID: 11739740
[TBL] [Abstract][Full Text] [Related]
19. ErbB-4 activation inhibits apoptosis in PC12 cells.
Erlich S; Goldshmit Y; Lupowitz Z; Pinkas-Kramarski R
Neuroscience; 2001; 107(2):353-62. PubMed ID: 11731109
[TBL] [Abstract][Full Text] [Related]
20. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3.
Vartanian T; Goodearl A; Viehöver A; Fischbach G
J Cell Biol; 1997 Apr; 137(1):211-20. PubMed ID: 9105049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
